XML 24 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Equity - USD ($)
Total
Preferred stock
Common stock
Common stock
Common Class A
Additional paid-in capital
Other Additional paid in capital
Other Additional paid in capital
Employee stock notes
Retained earnings
Accumulated other comprehensive income (loss)
Foreign currency adjustments
Unrealized (loss) gain on interest rate hedges
Net actuarial pension (loss) gain
Balance at beginning of period, shares at Dec. 31, 2018   0   101,310,862                
Balance at beginning of period at Dec. 31, 2018   $ 0   $ 1,013,000   $ 659,241,000 $ (648,000) $ 246,833,000   $ (144,805,000)    
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards, shares       303,093                
Shares issued for exercise/vesting of share-based compensation awards       $ 3,000   1,287,000            
Shares repurchased, shares     (939,798)                  
Shares repurchased     $ (15,000,000.0) $ (9,000)       (14,990,000)        
Shares surrendered for tax obligations for employee share-based transactions, shares       (9,335)                
Shares surrendered for tax obligations for employee share-based transactions       $ 0   (164,000)            
Amortization of share-based compensation           2,473,000            
Distributions/ net issuances             (6,000)          
Net income $ 15,777,000             15,777,000        
Foreign currency adjustments (12,046,000)                 (12,046,000)    
Unrealized gain on interest rate hedges 550,000                   $ 550,000  
Net actuarial pension gain 1,454,000                     $ 1,454,000
Balance at end of period at Mar. 30, 2019 756,724,000     $ 1,007,000 $ 662,183,000 662,837,000 (654,000) 248,381,000 $ (154,847,000)      
Balance at period end, shares at Mar. 30, 2019       100,664,822                
Balance at beginning of period, shares at Dec. 31, 2019   0   100,668,003                
Balance at beginning of period at Dec. 31, 2019 812,087,000 $ 0   $ 1,007,000   672,445,000 (673,000) 290,583,000   (151,275,000)    
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards, shares       94,471                
Shares issued for exercise/vesting of share-based compensation awards       $ 1,000   0            
Shares repurchased, shares     (265,589)                  
Shares repurchased     $ (5,000,000.0) $ (3,000)       (4,997,000)        
Shares surrendered for tax obligations for employee share-based transactions, shares       (9,400)                
Shares surrendered for tax obligations for employee share-based transactions       $ 0   (237,000)            
Amortization of share-based compensation           3,733,000            
Distributions/ net issuances             0          
Net income (230,000)             (230,000)        
Foreign currency adjustments (53,639,000)                 $ (53,639,000)    
Unrealized gain on interest rate hedges 0                      
Net actuarial pension gain 2,763,000                     $ 2,763,000
Balance at end of period at Mar. 28, 2020 $ 753,768,000     $ 1,005,000 $ 675,268,000 $ 675,941,000 $ (673,000) $ 279,646,000 $ (202,151,000)      
Balance at period end, shares at Mar. 28, 2020       100,487,485